Petersenn, S. et al. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat. Rev. Endocrinol. 19, 722–740 (2023).

Article  PubMed  Google Scholar 

Song, Z. J. et al. The genome-wide mutational landscape of pituitary adenomas. Cell Res. 26, 1255–1259 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Neou, M. et al. Pangenomic classification of pituitary neuroendocrine tumors. Cancer Cell 37, 123–134.e5 (2020).

Article  CAS  PubMed  Google Scholar 

Zhang, F. et al. Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors. Cell Res. 32, 1047–1067 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li, C. et al. Somatic SF3B1 hotspot mutation in prolactinomas. Nat. Commun. 11, 2506 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Simon, J. et al. Prevalence and clinical correlations of SF3B1 variants in lactotroph tumours. Eur. J. Endocrinol. 189, 372–378 (2023).

Article  PubMed  Google Scholar 

Duhamel, C. et al. Immunotherapy in corticotroph and lactotroph aggressive tumors and carcinomas: two case reports and a review of the literature. J. Pers. Med. 10, 88 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Tang, H. et al. Case report: temozolomide treatment of refractory prolactinoma resistant to dopamine agonists. Front. Endocrinol. (Lausanne) 12, 616339 (2021).

Article  PubMed  Google Scholar 

Raverot, G. et al. European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. Eur. J. Endocrinol. 178, G1–G24 (2018).

Article  CAS  PubMed  Google Scholar